PlainPharmaWatch

CMS Open Payments · Tool

Cambridge Interventional LLC vs Spinevision SAS

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Spinevision SAS has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,765, versus 756 for the other company. Its single largest recorded recipient represents 73.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Cambridge Interventional LLC
HHI 756 · top recipient 9.6%
Ranked #1,147 of 1,838 companies by HHI
Spinevision SAS
HHI 5,765 · top recipient 73.7%
Ranked #278 of 1,838 companies by HHI

Payment Overview

Total Payments
$66.1K
% of Industry
0.0%
Transactions
36
Avg per Transaction
$1.8K
Recipients
36
Avg per Recipient
$1.8K
Payment Types
2
Top Payment Type
Long-Term Medical Supply or Device Loan
Company B

Spinevision SAS

Total Payments
$66.0K
% of Industry
0.0%
Transactions
12
Avg per Transaction
$5.5K
Recipients
12
Avg per Recipient
$5.5K
Payment Types
4
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Cambridge Interventional LLC vs Spinevision SAS - total reported payments in CMS Open Payments PY2024

Cambridge Interventional LLC$66.1KSpinevision SAS$66.0K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Cambridge Interventional LLC

Long-Term Medical Supply or Device Loan $60.0K

90.8%

Food and Beverage $6.1K

9.2%

Spinevision SAS

Royalty or License $48.4K

73.4%

Travel and Lodging $14.5K

22.0%

Consulting Fee $2.0K

3.0%

Food and Beverage $1.0K

1.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Cambridge Interventional LLC

  1. 1

    SAKA KAZEEM

    $6,328.63 · 2 txns

  2. 2

    ALIREZA FALAHATI-NINI

    $6,003.60 · 2 txns

  3. 3

    SEAN NIKRAVAN

    $6,000.00 · 1 txns

  4. 4

    Brigham And Womens Hospital

    $6,000.00 · 1 txns

  5. 5

    Lahey Clinic Hospital Inc.

    $6,000.00 · 1 txns

Spinevision SAS

  1. 1

    Gary Colon

    $48,608.00 · 3 txns

  2. 2

    Pawel Jankowski

    $9,966.00 · 2 txns

  3. 3

    Vivek Mehta

    $6,730.00 · 2 txns

  4. 4

    Rebecca Kuo

    $217.00 · 1 txns

  5. 5

    Hamad Farhat

    $120.00 · 1 txns

Summary Comparison

Metric Cambridge Interventional LLC Spinevision SAS
Total Payments $66.1K $66.0K
% of Industry Total 0.0% 0.0%
Transaction Count 36 12
Avg per Transaction $1.8K $5.5K
Recipient Count 36 12
Avg per Recipient $1.8K $5.5K
Payment Type Count 2 4
Top Payment Type Long-Term Medical Supply or Device Loan Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.